Lipidomic profiling of sinus mucosa from patients with chronic rhinosinusitis
© 2015 Wiley Periodicals, Inc..
Sinusitis is a cause of significant morbidity, substantial healthcare costs, and negative effects on quality of life. The primary objective of this study is to characterize the previously unknown lipid profile of sinonasal mucosa from patients with chronic rhinosinusitis (CRS) and from controls. Sinus mucosa samples were analyzed from 9 CRS patients with concomitant nasal polyps, 11 CRS patients without polyps, and 12 controls. Ten lone polyp samples were also analyzed. Samples were subjected to a modified Bligh/Dyer lipid extraction, then high performance thin layer chromatography (HPTLC), combined gas chromatography/electron impact-mass spectrometry (GC/EI-MS), and flow-injection/electrospray ionization-tandem mass spectrometry (FI/ESI-MS/MS). Data was analyzed for identification and profiling of major components. HPTLC revealed an array of species reflecting the lipid complexity of the samples. GC/EI-MS revealed cholesterol and several fatty acids. FI/ESI-MSMS revealed numerous lipid species, namely a host of phosphatidylcholines, phosphatidylethanolamines, ceramides and cholesteryl esters, but no detectable amounts of phosphatidyinositols or sulfated lipids. These results are a first step to uncover unique molecular biomarkers in CRS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Clinical and translational science - 8(2015), 2 vom: 14. Apr., Seite 107-15 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fazlollahi, Farbod [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 12.01.2016 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/cts.12256 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM245341722 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM245341722 | ||
003 | DE-627 | ||
005 | 20231224140649.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/cts.12256 |2 doi | |
028 | 5 | 2 | |a pubmed24n0817.xml |
035 | |a (DE-627)NLM245341722 | ||
035 | |a (NLM)25588779 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fazlollahi, Farbod |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lipidomic profiling of sinus mucosa from patients with chronic rhinosinusitis |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.01.2016 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2015 Wiley Periodicals, Inc. | ||
520 | |a Sinusitis is a cause of significant morbidity, substantial healthcare costs, and negative effects on quality of life. The primary objective of this study is to characterize the previously unknown lipid profile of sinonasal mucosa from patients with chronic rhinosinusitis (CRS) and from controls. Sinus mucosa samples were analyzed from 9 CRS patients with concomitant nasal polyps, 11 CRS patients without polyps, and 12 controls. Ten lone polyp samples were also analyzed. Samples were subjected to a modified Bligh/Dyer lipid extraction, then high performance thin layer chromatography (HPTLC), combined gas chromatography/electron impact-mass spectrometry (GC/EI-MS), and flow-injection/electrospray ionization-tandem mass spectrometry (FI/ESI-MS/MS). Data was analyzed for identification and profiling of major components. HPTLC revealed an array of species reflecting the lipid complexity of the samples. GC/EI-MS revealed cholesterol and several fatty acids. FI/ESI-MSMS revealed numerous lipid species, namely a host of phosphatidylcholines, phosphatidylethanolamines, ceramides and cholesteryl esters, but no detectable amounts of phosphatidyinositols or sulfated lipids. These results are a first step to uncover unique molecular biomarkers in CRS | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a fatty acids | |
650 | 4 | |a lipids | |
650 | 4 | |a metabolism | |
650 | 4 | |a polyps | |
650 | 4 | |a tissue | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Ceramides |2 NLM | |
650 | 7 | |a Cholesterol Esters |2 NLM | |
650 | 7 | |a Lipids |2 NLM | |
650 | 7 | |a Phosphatidylcholines |2 NLM | |
650 | 7 | |a Phosphatidylethanolamines |2 NLM | |
700 | 1 | |a Kongmanas, Kessiri |e verfasserin |4 aut | |
700 | 1 | |a Tanphaichitr, Nongnuj |e verfasserin |4 aut | |
700 | 1 | |a Mallen-St Clair, Jon |e verfasserin |4 aut | |
700 | 1 | |a Gopen, Quinton |e verfasserin |4 aut | |
700 | 1 | |a Faull, Kym F |e verfasserin |4 aut | |
700 | 1 | |a Suh, Jeffrey D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and translational science |d 2008 |g 8(2015), 2 vom: 14. Apr., Seite 107-15 |w (DE-627)NLM186388268 |x 1752-8062 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2015 |g number:2 |g day:14 |g month:04 |g pages:107-15 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/cts.12256 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2015 |e 2 |b 14 |c 04 |h 107-15 |